ALL KEYWORDSNeonatal Alloimmune ThrombocytopeniaRelated SpecialistsStephanie MassaroMD, MPHMary Jane HoganMD, MPHAsher MarksMDRelated Clinical TrialsA prospective, natural history study to assess the occurrence of HPA-1a alloimmunization in women identified at higherrisk for Fetal and Neonatal Alloimmune Thrombocytopenia(FNAIT)Gender:Female onlyAge:18 years and olderThe NICU Antibiotics and Outcomes Trial (NANO)Pregnancy & ObstetricsGender:All Genders
